Vikas Jain, MD
Sleep Medicine · Frisco, TXNPI 1992965156
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $504,808 of the $673,350 with a category attached, or 75.0%. Jazz Pharmaceuticals Inc. accounts for 64.7% of it on its own, with 22 other manufacturers making up the rest. 2025 is the largest year on record at $172,527, 3.1 times the $55,852 reported in 2019. Among sleep medicine clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 860 payments — averaging $782.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Jazz Pharmaceuticals Inc.$436K
- Idorsia Pharmaceuticals US Inc$68K
- Inspire Medical Systems, Inc.$49K
- Lilly USA, LLC$45K
- Avadel CNS Pharmaceuticals, LLC$45K
- Harmony Biosciences LLC$15K
- plus $16K from 17 others
What the payments were for
- Consulting fees$68,05810%
- Speaking & faculty fees$504,80875%
- Travel & lodging$73,04811%
- Food & beverage$26,9074%
- Education$5280%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Jazz Pharmaceuticals Inc. | 521 | $435,833 |
| Idorsia Pharmaceuticals US Inc | 67 | $67,502 |
| Inspire Medical Systems, Inc. | 67 | $49,028 |
| Lilly USA, LLC | 50 | $45,117 |
| Avadel CNS Pharmaceuticals, LLC | 61 | $44,537 |
| Harmony Biosciences LLC | 33 | $14,933 |
| Axsome Therapeutics, Inc. | 21 | $13,554 |
| ZOLL Respicardia, Inc. | 3 | $1,606 |
| Novo Nordisk | 4 | $238 |
| Eisai Inc. | 12 | $199 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 2 | $195 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $125 |
| Fisher & Paykel Healthcare Inc | 1 | $95 |
| Resmed Corp | 4 | $78 |
| GSK | 4 | $72 |
| Itamar Medical Inc | 1 | $46 |
| Medtronic | 1 | $39 |
| Somnomed Inc. | 1 | $34 |
| Abbott | 1 | $32 |
| Ensodata, Inc. | 1 | $27 |
| Arbor Pharmaceuticals, Inc. | 2 | $25 |
| Vapotherm Inc | 1 | $22 |
| Philips North America LLC | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$673,350 in reported general payments places this provider in the 95th percentile of 112 sleep medicine providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XywavSodium,calcium,mag,pot Oxybate | 11 | $163,399 |
| BelsomraSuvorexant | 19 | $8,255 |
| QuviviqDaridorexant Hcl | 13 | $6,195 |
| DayvigoLemborexant | 16 | $5,327 |
| Zolpidem Tartrate ErZolpidem Tartrate | 15 | $1,526 |
| Modafinil | 24 | $1,351 |
| Zolpidem Tartrate | 88 | $663 |
| Pramipexole DihydrochloridePramipexole Di-Hcl | 27 | $251 |
| Ropinirole Hcl | 16 | $193 |
| Trazodone Hcl | 14 | $123 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Idorsia Pharmaceuticals US IncQuviviq | $67,502 | $6,19513 claims |
| Eisai Inc.Dayvigo | $199 | $5,32716 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 112 sleep medicine providers in Texas.
Other sleep medicine in Frisco
- Brent StevensonFrisco$9K
- Gerard MeskillSugar Land$1M
- Amit VermaHouston$493K
- Jerald SimmonsHouston$165K
- James AndrySan Antonio$100K
- William BurkesBeaumont$99K
- Ashwin GowdaAustin$71K
- John DebusDallas$38K
- Peter ObessoTyler$34K
- Karen Hentschel FranksSan Antonio$18K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.